|
1
|
Emadzadeh M, Shahidsales S, Mohammadian
Bajgiran A and Salehi M, Massoudi T, Nikfarjam Z and Salehi M: Head
and neck cancers in North-East Iran: A 25 year survey. Iran J
Otorhinolaryngol. 29:137–145. 2017.PubMed/NCBI
|
|
2
|
Genç R, Çağlı S, Yüce İ, Vural A, Okuducu
H, Patıroğlu T and Güney E: The role of H. pylori in the
development of laryngeal squamous cell carcinoma. Dis Markers.
35:447–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang S, Wu J, Song Y and Zhong H:
Expression of endothelin-1 in laryngocarcinoma tissues and its
clinical significance. Oncol Lett. 11:3366–3368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Haws L Jr and Haws BT: Aerodigestive
cancers: Laryngeal cancer. FP Essent. 424:26–31. 2014.PubMed/NCBI
|
|
5
|
Setiawan IGB and Adiputra PAT: A
successful tracheal resection and anastomosis in papillary thyroid
carcinoma with tracheal invasion. Open Access Maced J Med Sci.
6:2161–2164. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu X, Ma C, Fu L, Dong J and Ying J:
MicroRNA-139 inhibits the proliferation, migration and invasion of
gastric cancer cells by directly targeting ρ-associated protein
kinase 1. Oncol Lett. 15:5977–5982. 2018.PubMed/NCBI
|
|
7
|
Seux M, Iovanna J, Dagorn JC and Dusetti
NJ: MicroRNAs in pancreatic ductal adenocarcinoma: New diagnostic
and therapeutic clues. Pancreatology. 9:66–72. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alkhubaizi Q, Khalaf ME, Dashti H and
Sharma PN: Oral cancer screening among smokers and nonsmokers. J
Int Soc Prev Community Dent. 8:553–559. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ding Y, Wu Y, Gao W, Zhang C, Zhao Q, Guo
H, Qu X, Wen S and Wang B: Analysis of gene expression profiling
variations induced by hsa-miR-145-5p-overexpression in laryngeal
squamous cell carcinoma cell line Tu-177. Mol Med Rep.
16:5863–5870. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Elser H, Falconi AM, Bass M and Cullen MR:
Blue-collar work and womens health: A systematic review of the
evidence from 1990 to 2015. SSM Popul Health. 6:195–244. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Citil S, Dogan S, Atilgan HI, Menzilcioglu
MS, Sahin T, Abdulrezzak U, Duymus M and Ozturk M: Comparison of
dynamic contrast-enhanced MRI and PET/CT in the evaluation of
laryngeal cancer after inadequate CT results. Pol J Radiol.
80:428–432. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hamilton NJI and Birchall MA:
Tissue-engineered larynx: Future applications in laryngeal cancer.
Curr Otorhinolaryngol Rep. 5:42–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu X and Li Z: The role of microRNAs
expression in laryngeal cancer. Oncotarget. 6:23297–23305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Farrokhnia F, Aplin JD, Westwood M and
Forbes K: MicroRNA regulation of mitogenic signaling networks in
the human placenta. J Biol Chem. 289:30404–30416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang
W and Li L: MicroRNA-145 inhibits tumour growth and metastasis in
colorectal cancer by targeting fascin-1. Br J Cancer.
110:2300–2309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alajez NM, Lenarduzzi M, Ito E, Hui AB,
Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, et al: MiR-218
suppresses nasopharyngeal cancer progression through downregulation
of survivin and the SLIT2-ROBO1 pathway. Cancer Res. 71:2381–2391.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Misawa K, Imai A, Mochizuki D, Mima M,
Endo S, Misawa Y, Kanazawa T and Mineta H: Association of TET3
epigenetic inactivation with head and neck cancer. Oncotarget.
9:24480–24493. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Karatas OF, Yuceturk B, Suer I, Yilmaz M,
Cansiz H, Solak M, Ittmann M and Ozen M: Role of miR-145 in human
laryngeal squamous cell carcinoma. Head Neck. 38:260–266. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng Y, Yang X, Deng X, Zhang X, Li P,
Tao J and Lu Q: MicroRNA-218 inhibits bladder cancer cell
proliferation, migration, and invasion by targeting BMI-1. Tumour
Biol. 36:8015–8023. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Feng J, Fan Y, Ayiheng Q, Zhang H, Yong J
and Hu B: MicroRNA-125b targeted STAT3 to inhibit laryngeal
squamous cell carcinoma cell growth and motility. Oncol Lett.
14:480–486. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karatas OF, Suer I, Yuceturk B, Yilmaz M,
Hajiyev Y, Creighton CJ, Ittmann M and Ozen M: The role of miR-145
in stem cell characteristics of human laryngeal squamous cell
carcinoma Hep-2 cells. Tumour Biol. 37:4183–4192. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao X, Zhang W and Ji W: MYO5A inhibition
by miR-145 acts as a predictive marker of occult neck lymph node
metastasis in human laryngeal squamous cell carcinoma. Onco Targets
Ther. 11:3619–3635. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xin SY, Feng XS, Zhou LQ, Sun JJ, Gao XL
and Yao GL: Reduced expression of circulating microRNA-218 in
gastric cancer and correlation with tumor invasion and prognosis.
World J Gastroenterol. 20:6906–6911. 2014. View Article : Google Scholar : PubMed/NCBI
|
